Clonality Assessment in Blood of Patients with Mantle Cell Lymphoma

References

• The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma. Blood 1997; 11: 3909–3918
   Google Scholar
• Zucca E., Stein H., Coiffer B. European Lymphomas Task Force (ELTF): Report of the workshop on the Mantle Cell Lymphoma (MCL). Annals of Oncology 1994; 5: 507–511
   PubMed Web of Science ®Google Scholar
• Weisenburger D.D., Armitage J.O. Mantle cell lymphoma: an entity comes of age. Blood 1996; 87: 4483–4494
   PubMed Web of Science ®Google Scholar
• de Boer C.J., Loyson S., Kluin P.M., Kluin-Nelemans H.C., Schuuring E., Krieken J.H.J.M. Multiple breakpoints within the BCL-1 locus in B-cell lymphoma: rearrangements ofthe cyclin D1 gene. Cancer Research 1993; 53: 4148–4152
   PubMed Web of Science ®Google Scholar
• Harris N.L., Jaffe E.S., Stein H., Banks P.M., Chan J.K.C., Cleary M.L., Delsol G., De Wolf-Peeters C., Falini B., Gatter K.C., Grogan T.M., Isaacson P.G., Knowles D.M., Mason D.Y., Muller-Hermelink H.K., Pileri S.A., Piris M.A., Ralfkiaer E., Wamke R.A. A Revised-European-American Classification of Lymphoid Neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361–92
   PubMed Web of Science ®Google Scholar
• Zucca E., Bertoni F., Bosshard G., Roggero E., Ceresa E., Sanna P., Pedrinis E., Cavalli F. Clinical significance of bcl-2 (MBR) /JH rearrangement in the peripheral blood of patients with diffuse, large B-cell lymphomas. Annals of Oncology 1996; 7: 1023–1027
   PubMed Web of Science ®Google Scholar
• Molot R.J., Meeker T.C., Wittwer C.T., Perkins S.L., Segal G.H., Masih A.S., Braylan R.C., Kjeldsberf C.R. Antigen expression and polymerase chain reaction amplification of mantle cell lymphomas. Blood 1994; 6: 1626–1631
   Google Scholar
• Williams M.E., Swerdlow S.H., Meeker T.C. Chromosome t(11;14)(q13;q32) breakpoints in centrocytic lymphoma are highly localized at the bcl-1 major translocation cluster. Leukemia 1993; 7: 1437–1440
   PubMed Web of Science ®Google Scholar
• Raynaud S.D., Bekri S., Leroux D., Grosgeorge J., Klein B., Bastard C., Gaudray P., Simon M.P. Expanded range of 11q13 breakpoints with differing patterns of cyclin D1 expression in B-cell malignancies. Genes, Chromomom and Cancer 1993; 8: 80
   PubMed Web of Science ®Google Scholar
• Diss T.C., Peng H., Wotherspoon A.C., Isaacson P.G., Pan L. Detection of monoclonality in low-grade B-cell lymphomas using the polymerase chain reaction is dependent on primer selection and lymphoma type. Journal of Pathology 1993; 169: 291–295
   PubMed Web of Science ®Google Scholar
• Goulden N., Langlands K., Steward C., Knechtli C., Potter M., Oakhill T. PCR of gene rearrangements for the detection of minimal residual disease in childhood ALL. Methods In Molecular Medicine, Molecular Diagnosis of Cancer, F.E. Cotter. Humana Press, Totowa, NJ 1996; 3–23
   Google Scholar
• Beishuizen A., de Bruijn M.A.C., Pongers-Willemse M.J., Verhoeven M.A.J., van Wering E.R., Hählen K., Breit T.M., de Bruin-Versteeg S., Hooijkaas H., van Dongen J.J.M. Heterogeneity in junctional regions of immunoglobulin kappa deleting element rearrangements in B cell leukemias: a new molecular target for detection of minimal residual disease. Leukemia 1997; 11: 2200–2207
   PubMed Web of Science ®Google Scholar
• Küppers R., Hajadi M., Plank L., Rajewsky K., Hansmann M.L. Molecular Ig gene analysis reveals that monocytoid B cell lymphoma is a malignancy of mature B cells carrying somatically mutated V region genes and suggest that rearrangement of the kappadeleting element (resulting in deletion of the Ig kappa enhancers) abolishes somatic hypermutation in the human. European Journal of Immunology 1996; 26: 1794–1800
   PubMed Web of Science ®Google Scholar
• Segal G.H., Maiese R.L. Mantle cell lymphoma: rapid polymerase chain reaction-based genotyping of a morphologically heterogeneous entity. Archives of Pathology and Laboratory Medicine 1996; 120: 835–841
   PubMed Web of Science ®Google Scholar
• Abdel-Reheim F.A., Edwards E., Arber D.A. Utility of a rapid polymerase chain reaction panel for the detection of molecular changes in B-cell lymphoma. Archives of Pathology and Laboratory Medicine 1996; 120: 357–363
   PubMed Web of Science ®Google Scholar
• Luthra R., Hai S., Pugh W.C. Polymerase chain reaction detection of the t(11;14) translocation involving the bcl- 1 major translocation cluster in mantle cell lymphoma. Diagnostic Molecular Pathology 1995; 4: 4–7
   PubMed Web of Science ®Google Scholar
• Rimokh R., Berger F., Delsol G., Digonnet I., Rouault J.P., Tigaud J.D., Gadoux M., Coiffier B., Bryon P.A., Magaud J.P. Detection of the chromosomal translocation t(11;14) by polymerase chain reaction in mantle cell lymphomas. Blood 1994; 83: 1871–1875
   PubMed Web of Science ®Google Scholar
• Pinyol M., Campo E., Nadal A., Terol M.J., Jares P., Nayach I., Fernandez, Piris M.A., Montserrat E., Cardesa A. Detection of the bcl-1 rearrangement at the major translocation cluster in frozen and paraffin-embedded tissues of mantle cell lymphomas by polymerase chain reaction. American Journal of Clinical Pathology 1996; 105: 532–537
   PubMed Web of Science ®Google Scholar
• Du M.Q., Diss T.C., Xu C.F., Wotherspoon A.C., Isaacson P.G., Pan L.X. Ongoing immunoglobulin gene mutations in mantle cell lymphomas. British Journal of Haematology 1997; 96: 124–131
   PubMed Web of Science ®Google Scholar
• Hummel M., Tamaru J., Kalvelage B., Stein H. Mantle cell (previously centrocytic) lymphomas express VH genes with no or very little somatic mutations like the physiologic cells of the follicle mantle. Blood 1994; 84: 403–407
   PubMed Web of Science ®Google Scholar
• Kurokawa T., Kinoshita T., Murate T., Nagasaka T., Kagami Y., Ogura M., Nakamura S., Seto M., Hotta T., Saito H. Complementary determining region-III is a useful molecular marker for the evaluation of minimal residual disease in mantle cell lymphoma. British Journal of Haematology 1997; 98: 408–412
   PubMed Web of Science ®Google Scholar
• Corradini P., Astolfi M., Cherasco C., Ladetto M., Voena C., Caracciolo D., Pileri A., Tarella C. Molecular monitoring of minimal residual disease in follicular and mantle cell non-Hodgkin's lymphomas treated with high-dose chemotherapy and peripheral blood progenitor cell autografting. Blood 1997; 89: 724–731
   PubMed Web of Science ®Google Scholar
• Pittaluga S., Verhoef G., Criel A., Maes A., Nuyts J., Boogaerts M., De Wolf Peeters C. Prognostic significance of bone marrow trephine and peripheral blood smears in 55 patients with mantle cell lymphoma. Leukemia and Lymphoma 1996; 21: 115–125
   PubMed Web of Science ®Google Scholar
• Cabanillas F., Grillo-Lopez A.J., McLaughlin P., Link B.K., Levy R., Czuczman M., Heyman M.R., Williams M., Jain V., Bence-Bruckler I., Ho A.D., Lister J., Rogers J., Shen D., Vams C. Anti-CD20 antibody (MAB), IDEC-C2B8: clearance of bcl-2 t(14;18) positive cells from peripheral blood (PB) and bone marrow (BM) in patients (pts) with relapsed low-grade or follicular lymphoma (LG/F NHL). Blood 1996; 88 (suppl, 1): 91a
   Web of Science ®Google Scholar
• Bertoni F., Bosshard G., Roggero E., Ceresa E., Cavalli F., Zucca E. Clinical relevance of bd-2(MBR)/JH rearrangement detected by polymerase chain reaction in the peripheral blood of patients with follicular lymphoma. British Journal of Cancer 1997; 76: 36–39
   PubMed Web of Science ®Google Scholar